Yvonne Kennedy has over 25 years’ experience in the biopharmaceutical industry and significant technical, commercial and project management expertise in the development and commercialisation of oral and parenteral small molecule and biological products. Prior to joining Cilatus, Yvonne was the Vice President of Technical Operations, Project Management, and Strategy at Horizon Pharma, overseeing all project managers responsible for managing tech transfers for both a number of small molecule oral products and biologics in late-stage development and commercial settings. She was instrumental in developing project planning systems, processes and tools in constantly changing pharmaceutical development and operational environments.
At Alkermes Pharma she was the Senior Director, Head of Project Management, responsible for the planning, budgeting and tracking of development and commercial product support projects at the Athlone facility, Ireland. At Elan Drug Technologies she held the position of Senior Director, Head of Project Management, and she was responsible for planning, budgeting and tracking of development and commercial product support projects across 3 locations in Ireland and the US.
Yvonne holds a BSc. degree in Biochemistry and Chemistry, and PhD in Endocrinology from University College Dublin.
Since joining Cilatus, Yvonne has been acting as the CMC team leader for a small molecule for a client and she has been engaged in CDMO/CMO searches in the small molecule space.